RT Journal
A1 Mitka M
T1 STudies examine inflammatory biomarker in prevention and prediction of heart disease
JF JAMA
JO JAMA
YR 2009
FD January 7
VO 301
IS 1
SP 23
OP 24
DO 10.1001/jama.2008.876
UL http://dx.doi.org/10.1001/jama.2008.876
AB 
At the Scientific Sessions of the American Heart Association (AHA) held here in November, scientists reported that among apparently healthy patients with elevated levels of high-sensitivity C-reactive protein (hsCRP, an inflammatory biomarker) but without elevated low-density lipoprotein cholesterol (LDL-C) levels (< 130 mg/dL), using a statin reduced the LDL-C levels and significantly reduced the risk of myocardial infarction, stroke, and death.